iCARE One Step Multi-Drug Screening Test

Jal Medical is one of the leading manufacturers, exporters, and suppliers of the iCARE One Step Multi-Drug Screening Test. This rapid, qualitative, competitive lateral flow immunoassay is designed for the detection of drugs of abuse (DOA) and their metabolites in human urine. The device facilitates the detection of multiple drugs, ranging from 1 to 14 indicators, in a single, straightforward step.

One Step Multi-Drug Screening Test Key Features

• Multi-Drug Detection: Capable of identifying a wide array of drugs including:
  • Amphetamines (AMP)
  • Benzodiazepines (BZO)
  • Tricyclic Antidepressants (TCA)
  • Cocaine (COC)
  • Barbiturates (BAR)
  • Methadone (MTD)
  • Opiates (Morphine, OPI)
  • Phencyclidine (PCP)
  • Buprenorphine (BUP)
  • THC (Marijuana)
  • MDMA (Ecstasy)
  • Tramadol (TRA)
  • Methamphetamine (MET)
  • Ketamine (KET)

Specifications of One Step Multi-Drug Screening Test

• Test Type: Qualitative, competitive lateral flow immunoassay
• Sample Type: Human urine
• Detection Capability: From 1 to 14 drug indicators
• Usage: Single-step process for rapid results

Jal Medical supplies our advanced drug screening tests to a total of 57 African countries, including Nigeria, Ethiopia, Egypt, South Africa, and Kenya. We also serve the Caribbean region and Central Asia, ensuring the availability of reliable and efficient multi-drug screening tests across diverse regions.

Choose Jal Medical for accurate, comprehensive, and easy-to-use drug screening solutions, trusted by healthcare professionals worldwide.